Following a consecutive four-year low in China’s A-shares markets, the pharmaceutical and medical equipment sector bolstered by AI technology rebounded in February. Prices of both the major indexes and leading firms soared in the month, which could indicate a promising future for the industry where the pharmaceutical and equipment firms have made decade-long efforts to develop cost-effective products targeting the global market. These firms have been particularly profitable in the past two years after the use of AI accelerated their research and clinical data analyses. They are entitled to price their own innovative medicines which are covered by commercial medical insurance. The burgeoning industry has been noticed by overseas institutions like Goldman Sachs. However, experts warned that the complicated geopolitical situation may impact the industry, and companies should take this into account.
Old Version
